Literature DB >> 15901906

Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis.

K Oen1, P N Malleson, D A Cabral, A M Rosenberg, R E Petty, P Nickerson, M Reed.   

Abstract

OBJECTIVES: Single nucleotide polymorphisms (SNPs) in cytokine genes have been associated with risk of a number of autoimmune diseases. Moreover, some SNPs are associated with variations in rates of in vitro gene expression, and it is therefore possible that these functional polymorphisms may differentially affect inflammatory processes and disease outcome. This project's objective was to determine whether cytokine genotypes correlate with disease outcomes in patients with juvenile rheumatoid arthritis (JRA).
METHODS: Genotypes of SNPs of pro-inflammatory cytokines, tumour necrosis factor-alpha -308G -->A, interleukin-6 (IL-6) -174G -->C and interferon-gamma +874G -->A, and anti-inflammatory, immunosuppressive cytokines, interleukin-10 -1082G -->A, -819C -->T and -592A -->C and transforming growth factor-beta1 (TGF-beta1) codon 10T -->C and codon 25G -->C, were determined for patients with JRA who previously participated in a long-term outcome study. Cytokine genotypes and clinical variables showing significant correlations with clinical outcomes at the alpha = 0.100 level in univariate analyses were entered in multivariate tests.
RESULTS: In multivariate tests, the IL-6 genotype -174G/G was positively correlated with pain [regression coefficient B = 0.899, 95% confidence intervals (CI) 0.185, 1.612, P = 0.014]. The homozygous TGF-beta1 codon 25G/G genotype showed a protective effect against joint space narrowing on radiographs taken within 2 yr of disease onset, but confidence intervals were wide [odds ratio (OR) 0.176, 95% CI 0.037, 0.837 P = 0.029].
CONCLUSIONS: The correlation of IL-6 genotype with pain and the possible association of the TGF-beta1 codon 25 genotype with short-term radiographic damage (G/C with greater risk and G/G with decreased risk) suggests that both these polymorphisms may be useful early prognostic indicators. Further studies of the relation between cytokine genotypes and outcomes in patients with all forms of juvenile idiopathic arthritis (JIA) are warranted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15901906     DOI: 10.1093/rheumatology/keh689

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  17 in total

Review 1.  Defining juvenile idiopathic arthritis remission and optimum time for disease-modifying anti-rheumatic drug withdrawal: why we need a consensus.

Authors:  Thomas Broughton; Kate Armon
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

2.  Lack of association between IL-6 gene polymorphisms and rheumatoid arthritis in Turkish population.

Authors:  A Arman; A Coker; O Sarioz; N Inanc; H Direskeneli
Journal:  Rheumatol Int       Date:  2011-07-22       Impact factor: 2.631

Review 3.  Genetic predictors of acute and chronic pain.

Authors:  Robert R Edwards
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.592

Review 4.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

Review 5.  Molecular epidemiology, cancer-related symptoms, and cytokines pathway.

Authors:  Cielito C Reyes-Gibby; Xifeng Wu; Margaret Spitz; Razelle Kurzrock; Michael Fisch; Eduardo Bruera; Sanjay Shete
Journal:  Lancet Oncol       Date:  2008-08       Impact factor: 41.316

6.  The functional class evaluated in rheumatoid arthritis is associated with soluble TGF-β1 serum levels but not with G915C (Arg25Pro) TGF-β1 polymorphism.

Authors:  José Francisco Muñoz-Valle; Nora Magdalena Torres-Carrillo; Iris Paola Guzmán-Guzmán; Norma Torres-Carrillo; Sandra Luz Ruiz-Quezada; Claudia Azucena Palafox-Sánchez; Héctor Rangel-Villalobos; María Guadalupe Ramírez-Dueñas; Isela Parra-Rojas; Mary Fafutis-Morris; Blanca Estela Bastidas-Ramírez; Ana Laura Pereira-Suárez
Journal:  Rheumatol Int       Date:  2010-11-27       Impact factor: 2.631

Review 7.  Biological pathways and genetic variables involved in pain.

Authors:  Qiuling Shi; Charles S Cleeland; Pål Klepstad; Christine Miaskowski; Nancy L Pedersen
Journal:  Qual Life Res       Date:  2010-09-15       Impact factor: 4.147

8.  IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors.

Authors:  Rolando Cimaz; Marie-Angélique Cazalis; Charlotte Reynaud; Valeria Gerloni; Francesco Zulian; Martina Biggioggero; Giorgia Martini; Irene Pontikaki; Flavio Fantini; Bruno Mougin; Pierre Miossec
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

Review 9.  Progress in genetic studies of pain and analgesia.

Authors:  Michael L Lacroix-Fralish; Jeffrey S Mogil
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

Review 10.  Pharmacogenetics of chronic pain and its treatment.

Authors:  Svatopluk Světlík; Karolína Hronová; Hana Bakhouche; Olga Matoušková; Ondřej Slanař
Journal:  Mediators Inflamm       Date:  2013-05-20       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.